DE3587958D1 - Rekombinantes alveolares oberflächenaktives protein. - Google Patents

Rekombinantes alveolares oberflächenaktives protein.

Info

Publication number
DE3587958D1
DE3587958D1 DE3587958T DE3587958T DE3587958D1 DE 3587958 D1 DE3587958 D1 DE 3587958D1 DE 3587958 T DE3587958 T DE 3587958T DE 3587958 T DE3587958 T DE 3587958T DE 3587958 D1 DE3587958 D1 DE 3587958D1
Authority
DE
Germany
Prior art keywords
surface active
active protein
recombinant
alveolar surface
asp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3587958T
Other languages
English (en)
Other versions
DE3587958T2 (de
Inventor
James Schilling
Robert White
Barbara Cordell
Bradley Benson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Scios Nova Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scios Nova Inc filed Critical Scios Nova Inc
Publication of DE3587958D1 publication Critical patent/DE3587958D1/de
Application granted granted Critical
Publication of DE3587958T2 publication Critical patent/DE3587958T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE3587958T 1984-12-11 1985-12-10 Rekombinantes alveolares oberflächenaktives protein. Expired - Lifetime DE3587958T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/680,358 US4659805A (en) 1984-12-11 1984-12-11 Recombinant alveolar surfactant protein
PCT/US1985/002445 WO1986003408A1 (en) 1984-12-11 1985-12-10 Recombinant alveolar surfactant protein

Publications (2)

Publication Number Publication Date
DE3587958D1 true DE3587958D1 (de) 1995-01-19
DE3587958T2 DE3587958T2 (de) 1995-05-04

Family

ID=24730771

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3587958T Expired - Lifetime DE3587958T2 (de) 1984-12-11 1985-12-10 Rekombinantes alveolares oberflächenaktives protein.
DE19853590648 Ceased DE3590648T1 (de) 1984-12-11 1985-12-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19853590648 Ceased DE3590648T1 (de) 1984-12-11 1985-12-10

Country Status (14)

Country Link
US (1) US4659805A (de)
EP (1) EP0210189B1 (de)
JP (3) JPH07108917B2 (de)
KR (1) KR900004798B1 (de)
AT (1) ATE115147T1 (de)
AU (1) AU585579B2 (de)
DE (2) DE3587958T2 (de)
DK (1) DK172227B1 (de)
ES (1) ES8801517A1 (de)
GB (1) GB2181138B (de)
HK (1) HK1005883A1 (de)
IE (1) IE67067B1 (de)
NO (1) NO177678C (de)
WO (1) WO1986003408A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US5430020A (en) * 1984-12-11 1995-07-04 Scios Nova Inc. Recombinant alveolar surfactant protein
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
MX169643B (es) * 1985-04-12 1993-07-16 Oronzio De Nora Impianti Electrodo para procesos electroquimicos, procedimiento para su produccion y cuba de electrolisis conteniendo dicho electrodo
US4918161A (en) * 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
EP0240550A4 (de) * 1985-09-26 1989-09-19 Genetics Inst Lungen-oberflachenaktive proteine.
US5055553A (en) * 1985-09-26 1991-10-08 Genetics Institute Inc. Low molecular weight pulmonary surfactant proteins
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
WO1987006943A1 (en) * 1986-05-06 1987-11-19 Children's Hospital Medical Center Pulmonary hydrophobic surfactant-associated protein of 6,000 daltons molecular weight and multimers thereof
EP0290516A4 (de) * 1986-10-24 1989-11-14 Jeffrey A Whitsett Proteine, die mit oberflächenwirksamen hydrophoben lungenwirkstoffen verbunden sind.
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
WO1988005820A1 (en) * 1987-01-29 1988-08-11 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
EP0458167B1 (de) * 1990-05-21 1997-04-23 Abbott Laboratories Fettsäure-Oberflächenaktives-Lungenprotein Konjate
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
AU774207B2 (en) * 1999-01-19 2004-06-17 Nycomed Gmbh Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
CA2384861A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
JP2001137349A (ja) 1999-11-16 2001-05-22 Asahi Optical Co Ltd 内視鏡用噴霧具
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties
AU2002338882B2 (en) 2001-10-11 2008-04-03 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. Novel use of pulmonary surfactant
SE0203591D0 (sv) 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
AU2005268755B2 (en) 2004-08-06 2011-04-07 Takeda Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
AU2006203978B2 (en) 2005-01-06 2011-11-03 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
MX2009003002A (es) 2006-09-19 2009-06-01 Discovery Lab Inc Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
DE3688418T2 (de) * 1985-02-13 1993-08-26 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.

Also Published As

Publication number Publication date
EP0210189A1 (de) 1987-02-04
IE67067B1 (en) 1996-02-21
DE3590648T1 (de) 1987-02-19
JPS62501122A (ja) 1987-05-07
JP2500197B2 (ja) 1996-05-29
DK172227B1 (da) 1998-01-12
ATE115147T1 (de) 1994-12-15
EP0210189B1 (de) 1994-12-07
NO177678C (no) 1995-11-01
KR870700019A (ko) 1987-02-28
WO1986003408A1 (en) 1986-06-19
DK382786A (da) 1986-10-13
HK1005883A1 (en) 1999-01-29
EP0210189A4 (de) 1988-11-09
IE853133L (en) 1986-06-11
NO863197L (no) 1986-08-07
NO863197D0 (no) 1986-08-07
DK382786D0 (da) 1986-08-11
JPH07108917B2 (ja) 1995-11-22
ES549817A0 (es) 1988-01-16
US4659805A (en) 1987-04-21
AU585579B2 (en) 1989-06-22
AU5308986A (en) 1986-07-01
GB8619801D0 (en) 1986-09-24
DE3587958T2 (de) 1995-05-04
JPH0751066A (ja) 1995-02-28
NO177678B (no) 1995-07-24
KR900004798B1 (ko) 1990-07-06
GB2181138B (en) 1989-01-25
GB2181138A (en) 1987-04-15
JPH08224091A (ja) 1996-09-03
ES8801517A1 (es) 1988-01-16

Similar Documents

Publication Publication Date Title
DE3587958D1 (de) Rekombinantes alveolares oberflächenaktives protein.
ES2072850T3 (es) Proteina recombinante surfactante alveolar.
DK601786A (da) Hidtil ukendte prokoagulationsproteiner
ES2068791T1 (es) Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido.
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DK110190A (da) Alveolaere surfaktantproteiner
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
DE3777845D1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
NO991995L (no) Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
FI915654A (fi) Somatotropiner med alterneringar i alfahelixregionen 1 och kombinationer med andra mutationer.
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
IT8821667A0 (it) Procedimento per la preparazione di interleuchina 1 beta umana ricombinante in forma omogenea.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH, 78467 KO

8327 Change in the person/name/address of the patent owner

Owner name: ALTANA PHARMA AG, 78467 KONSTANZ, DE